Risk of fracture in users of hormonal contraception

Shaalini Ramanadhan; Jillian T Henderson; Amy Cantor; Robin A Paynter; Alison Edelman

doi:10.1002/14651858.CD015972

Risk of fracture in users of hormonal contraception

Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015972. doi: 10.1002/14651858.CD015972.

Authors

Shaalini Ramanadhan¹, Jillian T Henderson², Amy Cantor³, Robin A Paynter⁴, Alison Edelman¹

Affiliations

¹ Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
² Evidence-based Practice Center, Kaiser Permanente, Portland, OR, USA.
³ Department of Family Medicine, Oregon Health & Science University, Portland, OR, USA.
⁴ Oregon Health & Science University, Portland, OR, USA.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of hormonal contraception used for pregnancy prevention on fracture risk in individuals who are currently or were previously capable of becoming pregnant.

MeSH terms

Contraceptives, Oral, Hormonal / adverse effects
Female
Fractures, Bone* / chemically induced
Fractures, Bone* / prevention & control
Hormonal Contraception / adverse effects
Humans
Pregnancy
Randomized Controlled Trials as Topic

Substances

Contraceptives, Oral, Hormonal